• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Gildan Activewear

Gildan Activewear

Gildan Activewear Inc GIL

Last Price$27.90Day Change (%)-0.05%
Open Price$27.82Day Change ($)-0.02
Day Range27.74–27.8752-Week Range22.43–32.20

As of Tue 9/27/2016 10:52:00 AM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. ERYTECH Completes Patient Enrollment in Phase 2 Trial of eryaspase (GRASPA®) for Pancreatic Cancer

    ERYTECH Completes Patient Enrollment in Phase 2 Trial of eryaspase (GRASPA®) for Pancreatic Cancer

  2. For private investigators, divorce cases like Brangelina's can be good for business

    For private investigators, divorce cases like Brangelina's can be good for business

  3. UPDATE: Who's cheering Brangelina split? The private investigation industry

    UPDATE: Who's cheering Brangelina split? The private investigation industry

  4. Symmetry Electronics Joined by Digi International, Micronas, MultiTech, Silicon Labs, Silicon Motion and Telit as Gold Sponsor of ESC Minneapolis 2016

    Symmetry Electronics Joined by Digi International, Micronas, MultiTech, Silicon Labs, Silicon Motion and Telit as Gold Sponsor of ESC Minneapolis 2016

  5. Macy’s Celebrates Hispanic Heritage Month

    Macy’s Celebrates Hispanic Heritage Month

  6. 3dcart Shopping Cart Software Integrates with Amazon Payments

    3dcart Shopping Cart Software Integrates with Amazon Payments

  7. Rising Wine Pro Wins Sonoma Sommelier Star Challenge

    Rising Wine Pro Wins Sonoma Sommelier Star Challenge

  8. ERYTECH Appoints Allene M. Diaz to its Board of Directors

    ERYTECH Appoints Allene M. Diaz to its Board of Directors

  9. Kamada and Kedrion Seek FDA Approval of Human Rabies Immunoglobulin as a Post-Exposure Treatment

    Kamada and Kedrion Seek FDA Approval of Human Rabies Immunoglobulin as a Post-Exposure Treatment

  10. ERYTECH Completes Patient Enrollment in Phase 2b Trial for eryaspase (GRASPA®) in Acute Myeloid Leukemia

    ERYTECH Completes Patient Enrollment in Phase 2b Trial for eryaspase (GRASPA®) in Acute Myeloid Leukemia

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.